Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

Phase 2

3(50.0%)

N/A

3(50.0%)

6Total

Phase 2(3)

N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06623461Phase 2Recruiting

LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma

Role: collaborator

NCT06207136Not ApplicableRecruiting

Microbiome and Diet in Parkinson's Disease

Role: collaborator

NCT05469997Not ApplicableCompleted

Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome

Role: collaborator

NCT07341282Phase 2Not Yet Recruiting

Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis

Role: collaborator

NCT07213349Phase 2Recruiting

Daridorexant for Alzheimer Disease Prevention

Role: collaborator

NCT06515210Not ApplicableRecruiting

Personalized Anti-Inflammatory Fibres in Ulcerative Colitis

Role: collaborator

All 6 trials loaded